2024-05-19
2024-02-08
Summary | |
---|---|
Cancer Type | Esophageal Cancer |
Grade | IIIC |
Stage | T4N1M0,IIIa |
Ethnicity | Asian |
Gender | F |
Age | 63 |
Pathology Diagnosis | Adenocarcinoma derived from juncture of stomach and esophagus, protruded type, moderately-poorly differentiated, tumor mass: 4cm x 3.5cm. No malignant cells adjacent to esophageal stump and duodenal stump. Regional LN: right cardial LN (0/1), left cardial LN (5/5), LN of lesser curvature (0/5), inferior pyloric LN (0/4), LN of left gastric artery (3/5). IHC results: CD44(+), Cmet(+), EGFR(-), HER2(2+), Ki-67(+50-75%), MMP7(-), P170(weak +), P27(+>75%), P53(-), TOPOII(+25-50%) |
Biopsy Site | Esophagus |
Treatment History | NA |
Pathology QC | Moderately to poorly differentiated adenocarcinoma (P1, P6) |
Special Features | slight BW loss, ERBB2 amplified; FGFR1 slightly amplified (6) |
Mouse Strain | Balb/c nu |
TMA | TMA-HP-ES-014 |
Viral Status in PDX | NA |
Available In | CB_CN |
RNA Seq | P4 |
Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy